Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

333
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
333
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

164
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
164
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

123
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
123
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

266
Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
266
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

324
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
324
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

190
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
190

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Parenteral clomipramine for depression or obsessive-compulsive disorder: a systematic review and meta-analysis.

Acta neuropsychiatrica·2026
Same author

Assessing Patient Acceptance of Being Offered a Virtual Calm Room in Psychiatric Inpatient Care: Mixed Methods Study.

JMIR formative research·2025
Same author

Exploring the interplay between diet, obesity, mental health, and the gut microbiota: the MIND-GUT intervention study, study protocol.

Frontiers in nutrition·2025
Same author

The interrater reliability of the Swedish version of the Structured Clinical Interview for the DSM-5 Alternative Model for Personality Disorders, Module I and Module II for diagnosing personality disorders among adults referred to specialized psychiatric care - a pilot study.

BMC psychiatry·2025
Same author

Behavior Emotion Therapy System and You: Co-Design and Evaluation of a Mental Health Chatbot and Digital Human for Mild to Moderate Anxiety in Healthy Participants.

JMIR formative research·2025
Same author

When the caregiver is affected: eating disorder symptoms among mental health professionals.

Nordic journal of psychiatry·2025

Related Experiment Video

Updated: Dec 15, 2025

A Protocol for Safe Lithiation Reactions Using Organolithium Reagents
09:45

A Protocol for Safe Lithiation Reactions Using Organolithium Reagents

Published on: November 12, 2016

31.8K

Starting lithium in patients with compromised renal function - is it wise?

Mihaela Golic1, Harald Aiff1, Per-Ola Attman2

  • 1Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Journal of Psychopharmacology (Oxford, England)
|July 15, 2020
PubMed
Summary

Patients with pre-existing kidney problems face a significantly higher risk of severe kidney disease (chronic kidney disease stages 4-5) when starting lithium treatment. Older age and other health issues predict this progression.

Keywords:
Lithiumadverse effectschronic kidney diseasekidney failurerenal impairment

More Related Videos

In Situ Lithiated Reference Electrode: Four Electrode Design for In-operando Impedance Spectroscopy
09:36

In Situ Lithiated Reference Electrode: Four Electrode Design for In-operando Impedance Spectroscopy

Published on: September 12, 2018

9.1K
Solid-state Graft Copolymer Electrolytes for Lithium Battery Applications
05:33

Solid-state Graft Copolymer Electrolytes for Lithium Battery Applications

Published on: August 12, 2013

22.1K

Related Experiment Videos

Last Updated: Dec 15, 2025

A Protocol for Safe Lithiation Reactions Using Organolithium Reagents
09:45

A Protocol for Safe Lithiation Reactions Using Organolithium Reagents

Published on: November 12, 2016

31.8K
In Situ Lithiated Reference Electrode: Four Electrode Design for In-operando Impedance Spectroscopy
09:36

In Situ Lithiated Reference Electrode: Four Electrode Design for In-operando Impedance Spectroscopy

Published on: September 12, 2018

9.1K
Solid-state Graft Copolymer Electrolytes for Lithium Battery Applications
05:33

Solid-state Graft Copolymer Electrolytes for Lithium Battery Applications

Published on: August 12, 2013

22.1K

Area of Science:

  • Nephrology
  • Pharmacology
  • Clinical Medicine

Background:

  • The risks of initiating lithium treatment in patients with pre-existing compromised renal function are not well understood.
  • Assessing these risks is crucial for patient safety and treatment management.

Purpose of the Study:

  • To evaluate the risk of developing severe renal impairment, specifically chronic kidney disease (CKD) stages 4-5, in patients with compromised renal function at lithium treatment initiation.
  • To identify predictors for the progression of renal impairment in this patient group.

Main Methods:

  • A retrospective longitudinal cohort study was conducted using data from 1981-2017.
  • Two cohorts were compared: 83 patients with high serum creatinine before lithium treatment (exposed) and 83 matched patients with normal serum creatinine (reference).
  • Data were sourced from Sahlgrenska University Hospital's laboratory database, medical charts, and the Swedish Renal Registry.

Main Results:

  • The exposed cohort had a significantly higher risk of progressing to CKD stages 4-5 (Hazard Ratio 6.7, p < 0.001) compared to the reference cohort over a mean observation of 10 years.
  • Nearly half of the exposed patients progressed to CKD 4-5, versus only 10% in the reference group.
  • Older age at lithium initiation and a higher burden of comorbid somatic diseases, particularly cardiovascular diseases, were associated with progression.

Conclusions:

  • Compromised renal function before starting lithium treatment substantially increases the risk of developing severe renal impairment.
  • Monitoring renal function in patients on lithium should consider age and the presence of somatic comorbidities, especially cardiovascular conditions.